The store will not work correctly when cookies are disabled.
5-Nitro-furan-2-carboxylic acid dibenzylamide
ID: ALA4091464
PubChem CID: 3269063
Max Phase: Preclinical
Molecular Formula: C19H16N2O4
Molecular Weight: 336.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1ccc([N+](=O)[O-])o1)N(Cc1ccccc1)Cc1ccccc1
Standard InChI: InChI=1S/C19H16N2O4/c22-19(17-11-12-18(25-17)21(23)24)20(13-15-7-3-1-4-8-15)14-16-9-5-2-6-10-16/h1-12H,13-14H2
Standard InChI Key: LSBAOURNDLAOQW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
30.0173 -3.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8345 -3.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0889 -3.2102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4259 -2.7281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7672 -3.2102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8664 -2.9588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4729 -3.5064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0374 -2.1597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.9875 -2.9558 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3805 -3.5029 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8172 -2.1565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3019 -4.3055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2505 -3.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9085 -4.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4215 -2.4559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7333 -5.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3390 -6.1961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1175 -5.9448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2869 -5.1410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6798 -4.5971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2005 -2.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3717 -1.4077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7648 -0.8592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9840 -1.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8165 -1.9121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 1 0
6 8 2 0
9 10 2 0
9 11 1 0
5 9 1 0
7 12 1 0
7 13 1 0
12 14 1 0
13 15 1 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
15 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 15 1 0
M CHG 2 9 1 11 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.35 | Molecular Weight (Monoisotopic): 336.1110 | AlogP: 4.03 | #Rotatable Bonds: 6 |
Polar Surface Area: 76.59 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.81 | CX LogD: 3.81 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.50 | Np Likeness Score: -1.38 |
References
1. Arias DG, Herrera FE, Garay AS, Rodrigues D, Forastieri PS, Luna LE, Bürgi MD, Prieto C, Iglesias AA, Cravero RM, Guerrero SA.. (2017) Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase., 125 [PMID:27810595] [10.1016/j.ejmech.2016.10.055] |